---
schema_version: "secwatch.filing_event.v1"
accession: "0001515971-22-000039"
form_type: "8-K"
ticker: "INIS"
cik: "0001038277"
company_name: "RADNOSTIX INC"
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T05:50:57.370876+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# International Isotopes completes $4M asset sale to Pharmalogic; extends Series C Preferred maturity

## Summary
- Completed sale of manufacturing equipment and sublease to Pharmalogic Idaho for $4.0M cash on Feb 18, 2022.
- Series C Preferred Stock maturity extended by ~1 year to February 28, 2023, approved by majority of holders.
- Certificate of Amendment filed with Texas Secretary of State on Feb 16, 2022 to reflect the extension.
- The assets sold were acquired via a prior manufacturing and supply agreement termination.

## SEC filing metadata
- accession: 0001515971-22-000039
- form_type: 8-K
- ticker: INIS
- cik: 0001038277
- company_name: RADNOSTIX INC
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1038277/000151597122000039/0001515971-22-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1038277/000151597122000039/inis8k022222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001515971-22-000039
- JSON: https://secwatch.observer/filing/0001515971-22-000039.json
- Plain text: https://secwatch.observer/filing/0001515971-22-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.